129 related articles for article (PubMed ID: 36796661)
1. Reply to Comment on "Vigorous Physical Activity as a Risk factor for Central Serous Chorioretinopathy".
Cardillo Piccolino F; Fruttini D; Eandi C; Nicolò M; Mariotti C; Tito S; Lupidi M
Am J Ophthalmol; 2023 May; 249():185-186. PubMed ID: 36796661
[No Abstract] [Full Text] [Related]
2. Reply to Comment on: Vigorous Physical Activity as a Risk factor for Central Serous Chorioretinopathy.
Piccolino FC; Fruttini D; Eandi C; Nicolò M; Mariotti C; Tito S; Lupidi M
Am J Ophthalmol; 2023 May; 249():189-190. PubMed ID: 36587714
[No Abstract] [Full Text] [Related]
3. Comment on "Vigorous Physical Activity as a Risk Factor for Central Serous Chorioretinopathy".
Stewart MW
Am J Ophthalmol; 2023 May; 249():183-184. PubMed ID: 36801206
[No Abstract] [Full Text] [Related]
4. Comment on: Vigorous Physical Activity as a Risk Factor for Central Serous Chorioretinopathy.
Mohan S; Jain M
Am J Ophthalmol; 2023 May; 249():187-188. PubMed ID: 36587715
[No Abstract] [Full Text] [Related]
5. Comment on: Effect of short-term meditation training in central serous chorioretinopathy.
Panigrahi PK
Indian J Ophthalmol; 2022 May; 70(5):1856. PubMed ID: 35502102
[No Abstract] [Full Text] [Related]
6. Comment on: Effect of short-term meditation training in central serous chorioretinopathy.
Suryakanth S; Ramanjulu R; Shanmugam MP; Mishra DKC
Indian J Ophthalmol; 2022 May; 70(5):1854. PubMed ID: 35502100
[No Abstract] [Full Text] [Related]
7. Response to comment on: Effect of short-term meditation training in central serous chorioretinopathy.
Venkatesh P; Surve A
Indian J Ophthalmol; 2022 May; 70(5):1857. PubMed ID: 35502103
[No Abstract] [Full Text] [Related]
8. Response to comment on: Effect of short-term meditation training in central serous chorioretinopathy.
Venkatesh P; Surve A; Yadav R
Indian J Ophthalmol; 2022 May; 70(5):1855. PubMed ID: 35502101
[No Abstract] [Full Text] [Related]
9. Reply: To PMID 25158945.
Pang CE; Freund KB
Retina; 2015 Jul; 35(7):e40. PubMed ID: 26057396
[No Abstract] [Full Text] [Related]
10. Comparison of choroidal thickness among patients with healthy eyes, early age-related maculopathy, neovascular age-related macular degeneration, central serous chorioretinopathy, and polypoidal choroidal vasculopathy.
Kim SW; Oh J; Kwon SS; Yoo J; Huh K
Retina; 2011 Oct; 31(9):1904-11. PubMed ID: 21878855
[TBL] [Abstract][Full Text] [Related]
11. Reply to "Comment on Clinical Factors Related to Loculation of Fluid in Central Serous Chorioretinopathy".
Imanaga N; Koizumi H
Am J Ophthalmol; 2022 Sep; 241():295. PubMed ID: 35750214
[No Abstract] [Full Text] [Related]
12. Commentary: Retinal pigment epithelial leak identification in central serous chorioretinopathy: Is fundus fluorescein angiography a must?
Delhiwala K; Khamar B
Indian J Ophthalmol; 2022 Mar; 70(3):895-896. PubMed ID: 35225538
[No Abstract] [Full Text] [Related]
13. Can we classify central serous chorioretinopathy better? Yes we can.
Lotery A
Eye (Lond); 2022 Mar; 36(3):487. PubMed ID: 34645968
[No Abstract] [Full Text] [Related]
14. Light exposure in acute central serous chorioretinopathy.
Norouzpour A
Eye (Lond); 2022 Jan; 36(1):243. PubMed ID: 33423042
[No Abstract] [Full Text] [Related]
15. Commentary: Available evidence on early treatment of central serous chorioretinopathy.
Tripathy K; Mishra C; Addya S
Indian J Ophthalmol; 2021 Sep; 69(9):2348-2349. PubMed ID: 34427219
[No Abstract] [Full Text] [Related]
16. Salivary Alpha-Amylase Levels May Correlate With Central Serous Chorioretinopathy Activity.
Abdelhakim AH; Ledesma-Gil G; Yannuzzi LA
Retina; 2021 Oct; 41(10):2007-2008. PubMed ID: 34292223
[No Abstract] [Full Text] [Related]
17. Anxiolytics in the treatment of central serous chorioretinopathy.
Dudani AI; Dudani A; Dudani K; Dudani A
Indian J Ophthalmol; 2022 Feb; 70(2):701. PubMed ID: 35086281
[No Abstract] [Full Text] [Related]
18. Anxiolytics in the treatment of central serous chorioretinopathy.
Dudani AI; Dudani A; Dudani K; Dudani A
Indian J Ophthalmol; 2021 Oct; 69(10):2902-2903. PubMed ID: 34571681
[No Abstract] [Full Text] [Related]
19. Commentary: Acute central serous chorioretinopathy - Treat early, observe longer.
Kumar N; Parachuri N; Sharma A
Indian J Ophthalmol; 2021 Sep; 69(9):2347-2348. PubMed ID: 34427218
[No Abstract] [Full Text] [Related]
20. Macular Star Associated with Fibrinous Central Serous Chorioretinopathy.
Hara C; Wakabayashi T; Nishida K
Ophthalmology; 2023 Jan; 130(1):76. PubMed ID: 35773069
[No Abstract] [Full Text] [Related]
[Next] [New Search]
